Analytic Investors’s Chemed CHE Stock Holding History

Analytic Investors’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$2.17M	Hold	15,390	–	–	0.02%	263
2016 Q2	$2.1M	Sell	15,390 -1,238	-7%	-$164K	0.02%	276
2016 Q1	$2.25M	Sell	16,628 -537	-3%	-$72.6K	0.03%	293
2015 Q4	$2.57M	Sell	17,165 -4,752	-22%	-$702K	0.03%	259
2015 Q3	$2.92M	Buy	21,917 +309	+1%	+$43.3K	0.04%	245
2015 Q2	$2.83M	Sell	21,608 -4,746	-18%	-$587K	0.04%	236
2015 Q1	$3.15M	Buy	26,354 +1,809	+7%	+$201K	0.04%	209
2014 Q4	$2.59M	Buy	24,545 +12,504	+104%	+$1.32M	0.04%	227
2014 Q3	$1.24M	Buy	+12,041	New	+$1.22M	0.02%	341

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Analytic Investors's CHE Position: Q3 2016 in Review

Analytic Investors held its Chemed (CHE) position steady in Q3 2016 at 15,390 shares worth $2.17M. The position accounts for 0.02% of the portfolio, ranked #263.

Analytic Investors first reported a position in CHE in Q3 2014 and has held it in 9 quarters since. The position peaked at $3.15M in Q1 2015. 240 funds tracked by Wall St. Rank hold CHE as of Q3 2016.

Analytic Investors held 15,390 shares of Chemed worth $2.17M as of Q3 2016.
Analytic Investors left its Chemed share count unchanged in Q3 2016.
Chemed made up 0.02% of Analytic Investors's portfolio in Q3 2016, its #263 holding.
Analytic Investors first reported a position in Chemed in Q3 2014 and has held it in 9 quarters since.
Analytic Investors's Chemed position peaked at $3.15M in Q1 2015.
240 funds tracked by Wall St. Rank held Chemed as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.